Share on Facebook Share on Twitter Email
Answers.com

Platinum nanoparticles

 
Wikipedia: Platinum nanoparticles

Part of a series of articles on

Nanomaterials

Fullerenes

Carbon nanotubes
Fullerene chemistry
Applications
In popular culture
Timeline
Carbon allotropes

Nanoparticles

Quantum dots
Nanostructures
Colloidal gold
Silver nanoparticles
Iron nanoparticles
Platinum nanoparticles

See also
Nanotechnology
 v  d  e 

Platinum nanoparticles are usually in the form of a suspension or colloid[1] of sub-micrometre-sized particles of platinum[2] in a fluid, usually water. A colloid is technically defined as particles which remain suspended without forming an ionic, or dissolved solution. The broader commercial definition of "colloidal platinum" includes products that contain various concentrations of ionic platinum, platinum colloids, ionic platinum compounds or platinum nanoparticles in purified water.

The platinum nanoparticle sizes range between 2-3 nanometres (nm). Trillions of platinum nanoparticles are suspended in the brownish red or black colored colloidal solution. Nanoparticles come in wide variety of shapes including spheres, rods, cubes, and caps.

Due to the antioxidant properties of the platinum nanoparticles, they are the subject of substantial research with applications in a wide variety of areas, including nanotechnology, medicine and the synthesis of novel materials with unique properties.

Contents

Synthesis

Platinum nanoparticles[3] are fabricated by reduction of hexachloroplatinate. After dissolving hexachloroplatinate, the solution is rapidly stirred while a reducing agent is added. This causes platinum ions to be reduced to neutral platinum atoms. As more and more of these platinum atoms form, the solution becomes supersaturated and platinum gradually starts to precipitate in the form of sub-nanometre particles. The rest of the platinum atoms that form stick to the existing particles, and, if the solution is stirred vigorously enough, the particles will be fairly uniform in size. Various procedures employed to attain platinum nanoparticles include heating, reflux, cooling, stirring, filtration and filling, examinations & tests and packaging. To prevent the particles from aggregating, some sort of stabilizing agent or stabilizer that sticks to the nanoparticle surface is usually added. They can be functionalized with various organic ligands to create organic-inorganic hybrids with advanced functionality.

Biological effects

Research by Yusei Miyamoto at University of Tokyo, Japan,[4] resulted in the use of platinum nanoparticles[5] of the size 2-3 nm to increase the lifespan of the roundworm Caenorhabditis elegans.[6]

Nanoparticles may present possible safety issues both medically and environmentally.[7] Most of these issues usually arise due to the high surface to volume ratio, which can make the particles of some metals very reactive or catalytic.[8] In particular, inhaled nanoparticles can pose health risks,[9] and may cause inflammation and disease in the lung.[10] They are able to pass through cell membranes in organisms and their interactions with biological systems are relatively unknown. However, free nanoparticles in the environment quickly tend to agglomerate and thus leave the nano-regime, and nature itself presents many nanoparticles to which organisms on earth may have evolved immunity (such as salt particulates from ocean aerosols, terpenes from plants, or dust from volcanic eruptions).[citation needed]

See also

References

  1. ^ Conductive Polymer / Solvent Systems: Solutions or Dispersions?, Bernhard Wessling, 1996
  2. ^ Unknown Facts about Platinum
  3. ^ Creation of platinum nanoparticles (pdf)
  4. ^ Graduate school of Frontier Sciences, University of Tokyo, Japan, http://www.ib.k.u-tokyo.ac.jp/ib-E/index.html
  5. ^ Room temperature synthesis of colloidal platinum nanoparticles (pdf)
  6. ^ Kim J, Takahashi M, Shimizu T, et al (June 2008). "Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans". Mech. Ageing Dev. 129 (6): 322–31. doi:10.1016/j.mad.2008.02.011. PMID 18400258. 
  7. ^ De Jong WH, Borm PJ (2008). "Drug delivery and nanoparticles:applications and hazards". Int J Nanomedicine 3 (2): 133–49. PMID 18686775. 
  8. ^ Oberdörster G, Oberdörster E, Oberdörster J (July 2005). "Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles". Environ. Health Perspect. 113 (7): 823–39. PMID 16002369. PMC 1257642. http://ehpnet1.niehs.nih.gov/members/2005/7339/7339.html. 
  9. ^ Borm PJ, Kreyling W (May 2004). "Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery". J Nanosci Nanotechnol 4 (5): 521–31. doi:10.1166/jnn.2004.081. PMID 15503438. 
  10. ^ Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (March 2007). "Nanoparticles: pharmacological and toxicological significance". Br. J. Pharmacol. 150 (5): 552–8. doi:10.1038/sj.bjp.0707130. PMID 17245366. PMC 2189773. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17245366. 

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Platinum nanoparticles" Read more